Literature DB >> 7556303

Fluorine-18-fluorodeoxyglucose positron emission tomography for preoperative parathyroid imaging in primary hyperparathyroidism.

P Melon1, A Luxen, E Hamoir, M Meurisse.   

Abstract

Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging was performed in seven consecutive patients with primary hyperparathyroidism to preoperatively locate parathyroid adenomas. Foci of FDG accumulation corresponding to abnormal parathyroid tissue were observed in two out of nine surgically excised parathyroid adenomas. It was concluded that FDG PET imaging demonstrated a too low sensitivity for systematic preoperative detection and localization of parathyroid glands causing primary hyperparathyroidism.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7556303     DOI： 10.1007/bf00817282

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


  6 in total

1.  Use of 2-[F-18]-fluoro-2-deoxy-D-glucose PET to locate parathyroid adenomas in primary hyperparathyroidism.

Authors:  J C Sisson; N W Thompson; R J Ackerman; R L Wahl
Journal:  Radiology       Date:  1994-07       Impact factor: 11.105

2.  18F-fluorodeoxyglucose imaging in preoperative diagnosis of thyroid malignancy.

Authors:  H Joensuu; A Ahonen; P J Klemi
Journal:  Eur J Nucl Med       Date:  1988

3.  Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography.

Authors:  Y Ichiya; Y Kuwabara; M Otsuka; T Tahara; T Yoshikai; T Fukumura; K Jingu; K Masuda
Journal:  J Nucl Med       Date:  1991-09       Impact factor: 10.057

4.  Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG.

Authors:  B L Shulkin; R A Koeppe; I R Francis; G M Deeb; R V Lloyd; N W Thompson
Journal:  Radiology       Date:  1993-03       Impact factor: 11.105

5.  Primary hyperparathyroidism: preoperative parathyroid imaging with regional body FDG PET.

Authors:  D R Neumann; C B Esselstyn; W J MacIntyre; E Q Chen; R T Go; L M Kohse; A A Licata
Journal:  Radiology       Date:  1994-08       Impact factor: 11.105

6.  Influence of the blood glucose concentration on FDG uptake in cancer--a PET study.

Authors:  P Lindholm; H Minn; S Leskinen-Kallio; J Bergman; U Ruotsalainen; H Joensuu
Journal:  J Nucl Med       Date:  1993-01       Impact factor: 10.057
  6 in total
  10 in total

1.  FDG PET/CT findings in primary hyperparathyroidism mimicking multiple bone metastases.

Authors:  Hakan Demir; Metin Halac; Gozde D Gorur; Kerim Sonmezoglu; Ilhami Uslu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-12-11       Impact factor: 9.236

2.  ¹⁸F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study.

Authors:  Luka Lezaic; Sebastijan Rep; Mojca Jensterle Sever; Tomaz Kocjan; Marko Hocevar; Jure Fettich
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-07-26       Impact factor: 9.236

Review 3.  Imaging for primary hyperparathyroidism--an evidence-based analysis.

Authors:  Radu Mihai; Dietmar Simon; Per Hellman
Journal:  Langenbecks Arch Surg       Date:  2009-07-10       Impact factor: 3.445

4.  Pre-operative localisation of hyperfunctional parathyroid tissue with 11C-methionine PET.

Authors:  D Otto; A R Boerner; M Hofmann; T Brunkhorst; G J Meyer; T Petrich; G F Scheumann; W H Knapp
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-29       Impact factor: 9.236

5.  Scintigraphic techniques in primary hyperparathyroidism: from pre-operative localisation to intra-operative imaging.

Authors:  Domenico Rubello; Milton D Gross; Giuliano Mariani; Adil AL-Nahhas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-03-10       Impact factor: 10.057

Review 6.  Use of PET tracers for parathyroid localization: a systematic review and meta-analysis.

Authors:  Wouter P Kluijfhout; Jesse D Pasternak; Frederick Thurston Drake; Toni Beninato; Jessica E Gosnell; Wen T Shen; Quan-Yang Duh; Isabel E Allen; Menno R Vriens; Bart de Keizer; Miguel H Pampaloni; Insoo Suh
Journal:  Langenbecks Arch Surg       Date:  2016-04-16       Impact factor: 3.445

7.  2009 EANM parathyroid guidelines.

Authors:  Elif Hindié; Omer Ugur; David Fuster; Michael O'Doherty; Gaia Grassetto; Pablo Ureña; Andrew Kettle; Seza A Gulec; Francesca Pons; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-07       Impact factor: 9.236

8.  Incidental uptake of (18)F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer.

Authors:  Marina Hodolic; Virginie Huchet; Sona Balogova; Laure Michaud; Khaldoun Kerrou; Valérie Nataf; Marino Cimitan; Jure Fettich; Jean-Noël Talbot
Journal:  Radiol Oncol       Date:  2014-07-10       Impact factor: 2.991

9.  A Pilot Comparison of 18F-fluorocholine PET/CT, Ultrasonography and 123I/99mTc-sestaMIBI Dual-Phase Dual-Isotope Scintigraphy in the Preoperative Localization of Hyperfunctioning Parathyroid Glands in Primary or Secondary Hyperparathyroidism: Influence of Thyroid Anomalies.

Authors:  Laure Michaud; Sona Balogova; Alice Burgess; Jessica Ohnona; Virginie Huchet; Khaldoun Kerrou; Marine Lefèvre; Marc Tassart; Françoise Montravers; Sophie Périé; Jean-Noël Talbot
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

Review 10.  Fluorocholine PET Imaging of Parathyroid Disease.

Authors:  Meghana Prabhu; Nishikant A Damle
Journal:  Indian J Endocrinol Metab       Date:  2018 Jul-Aug
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.